Helicos Expands Licensing Deal with Arizona Technology Enterprise | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Helicos BioSciences has amended a licensing deal with Arizona Technology Enterprise to include the rights to sequencing-based detection methods that do not rely on optically-labeled nucleotides, the Cambridge, Mass.-based firm announced after the close of the market on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.